The apolipoprotein E (APOE) ε4 allele is the strongest genetic predictor of AD [1, 4], although among autopsy- or biopsy-confirmed AD cases the proportion of individuals not carrying the ε4 risk-allele ranges from 35 to 57% [5], which highlights the need for additional predictive markers. This evidence concerns the gene APOE and Alzheimer disease.